Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer DOI Creative Commons
Amy Body, Luxi Lal, Sriganesh Srihari

и другие.

Vaccine, Год журнала: 2024, Номер unknown, С. 126547 - 126547

Опубликована: Дек. 1, 2024

The COVID-19 pandemic has significantly impacted people with cancer. Initial vaccine studies excluded patients malignancy. Immunocompromised individuals remain vulnerable to SARS-CoV-2, necessitating detailed understanding of response. epidemiology in Australia offered unique opportunities study cancer populations minimal community exposure SARS-CoV-2.

Язык: Английский

Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity DOI
Sabryna Nantel, Salma Sheikh‐Mohamed, Gary Chao

и другие.

Mucosal Immunology, Год журнала: 2024, Номер 17(2), С. 201 - 210

Опубликована: Янв. 25, 2024

Язык: Английский

Процитировано

9
Durability of immune responses to SARS-CoV-2 infection and vaccination DOI
Mehul S. Suthar

Seminars in Immunology, Год журнала: 2024, Номер 73, С. 101884 - 101884

Опубликована: Май 1, 2024

Язык: Английский

Процитировано

5
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer DOI Creative Commons
Amy Body, Luxi Lal, Sriganesh Srihari

и другие.

Vaccine, Год журнала: 2024, Номер unknown, С. 126547 - 126547

Опубликована: Дек. 1, 2024

The COVID-19 pandemic has significantly impacted people with cancer. Initial vaccine studies excluded patients malignancy. Immunocompromised individuals remain vulnerable to SARS-CoV-2, necessitating detailed understanding of response. epidemiology in Australia offered unique opportunities study cancer populations minimal community exposure SARS-CoV-2.

Язык: Английский

Процитировано

3